Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
We analyzed the outcomes of 44 children with hepatitis associated aplastic anemia (HAA) who received immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine (CsA). Fourteen (31.8%) patients achieved complete response and 17 (38.6%) achieved partial response, for an overall response rate of 70.4% after 6 months. Seven non-responders received bone marrow transplantation from an HLA-matched unrelated donor and 6 out of 7 are alive. The probability of overall survival at 10 years was 88.3+/-4.9%, which supports the role of IST with ATG and CsA as treatment of choice for children with HAA without an HLA identical sibling donor.
Dept. of Pediatrics, Osaka General Medical Center, Osaka, Japan.
Yuko
Y
Osugi
Hiroshi
H
Yagasaki
Masahiro
M
Sako
Yoshiyuki
Y
Kosaka
Takashi
T
Taga
Tsuyoshi
T
Ito
Masuji
M
Yamamoto
Akira
A
Ohara
Takeyuki
T
Sato
Junichi
J
Mimaya
Ichiro
I
Tsukimoto
Seiji
S
Kojima
D000293:Adolescent; D000741:Anemia, Aplastic / Q000401:mortality / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006505:Hepatitis / Q000473:pathology / Q000628:therapy*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007223:Infant; D008297:Male; D015996:Survival Rate; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine